Pascale Moreau

2.3k citations

89 papers · 1.9k indexed · h-index 26

Impact in

Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents
Organic Chemistry top 2%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Quinazolinone synthesis and applications
- Catalytic C–H Functionalization Methods

Papers in

Toxicology 23
- Bioactive Compounds and Antitumor Agents 23
Organic Chemistry 52
- Synthesis and biological activity 23
- Synthesis and Biological Evaluation 15
- Quinazolinone synthesis and applications 13

Co-authors: Fabrice Anizon Michelle Prudhomme Eric Débiton F Giraud Lionel Nauton Vincent Théry Martine Sancelme Rufine Akué‐Gédu
Journals: European Journal of Medicinal Chemistry (19 papers)Bioorganic & Medicinal Chemistry (15 papers)Journal of Medicinal Chemistry (7 papers)Tetrahedron (5 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)
Partner nations: France Russia Norway

In The Last Decade

Pascale Moreau

85 papers receiving 1.8k citations

Peers

Countries citing papers authored by Pascale Moreau

Since Specialization

Citations

This map shows the geographic impact of Pascale Moreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascale Moreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascale Moreau more than expected).

Fields of papers citing papers by Pascale Moreau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascale Moreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascale Moreau. The network helps show where Pascale Moreau may publish in the future.

Co-authors

The 25 scholars most cited alongside Pascale Moreau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pascale Moreau Line = papers co-authored together Pascale Moreau links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Synthesis and biological activity of 1H-pyrrolo[3,2-g]isoquinolines as Haspin kinase inhibitors Bioorganic & Medicinal Chemistry ·Killian Malosse, Marie Ben Doula, Béatrice Josselin, Thomas Robert, Fabrice Anizon, Sandrine Ruchaud, F Giraud, Pascale Moreau	2025	0
2	The Nitro Group Reshapes the Effects of Pyrido[3,4-g]quinazoline Derivatives on DYRK/CLK Activity and RNA Splicing in Glioblastoma Cells Cancers ·Sophia S. Borisevich, Tatiana E. Aksinina, Margarita G. Ilyina, Victoria О. Shender, Ksenia S. Anufrieva, Georgij Arapidi, Н. В. Антипова, Fabrice Anizon, Yannick J. Esvan, F Giraud, Victor V. Tatarskiy, Pascale Moreau, M. I. Shakhparonov, Marat S. Pavlyukov, Аlexander А. Shtil	2024	2
3	Synthesis, kinase inhibition and anti-leukemic activities of diversely substituted indolopyrazolocarbazoles European Journal of Medicinal Chemistry ·T M Frazier, Elisabeth Pereira, Reidun Aesöy, Lionel Nauton, F Giraud, Lars Herfindal, Fabrice Anizon, Pascale Moreau	2024	2
4	Synthesis and biological evaluation of Haspin inhibitors: Kinase inhibitory potency and cellular activity European Journal of Medicinal Chemistry ·Waël Zeinyeh, Yannick J. Esvan, Béatrice Josselin, Mathilde Defois, Blandine Baratte, Stefan Knapp, A. Chaikuad, Fabrice Anizon, F Giraud, Sandrine Ruchaud, Pascale Moreau	2022	7
5	Improved potency of pyridin-2(1H)one derivatives for the treatment of mechanical allodynia European Journal of Medicinal Chemistry ·Alexia Visseq, Amélie Descheemaeker, Karine Hérault, F Giraud, Isabelle Abrunhosa‐Thomas, Alain Artola, Fabrice Anizon, Radhouane Dallel, Pascale Moreau	2021	2
6	A Kinase Inhibitor with Anti-Pim Kinase Activity is a Potent and Selective Cytotoxic Agent Toward Acute Myeloid Leukemia Molecular Cancer Therapeutics ·Ronja Bjørnstad, Reidun Aesöy, Øystein Bruserud, Annette K. Brenner, F Giraud, Tara Helén Dowling, Gro Gausdal, Pascale Moreau, Stein Ove Døskeland, Fabrice Anizon, Lars Herfindal	2019	15
7	Functionalization of 9-thioxanthone at the 1-position: From arylamino derivatives to [1]benzo(thio)pyrano[4,3,2-de]benzothieno[2,3-b]quinolines of biological interest Bioorganic Chemistry ·Nahida Mokhtari Brikci-Nigassa, Lionel Nauton, Pascale Moreau, Olivier Mongin, Raphaël E. Duval, Laurent Picot, Valérie Thiéry, Mohamed Souab, Blandine Baratte, Sandrine Ruchaud, Stéphane Bach, Rémy Le Guével, Ghenia Bentabed‐Ababsa, William Erb, Thierry Roisnel, Vincent Dorcet, Florence Mongin	2019	13
8	Synthesis and preliminary in vitro kinase inhibition evaluation of new diversely substituted pyrido[3,4-g]quinazoline derivatives Bioorganic & Medicinal Chemistry Letters ·Waël Zeinyeh, Yannick J. Esvan, Lionel Nauton, Nadège Loaëc, Laurent Meijer, Vincent Théry, Fabrice Anizon, F Giraud, Pascale Moreau	2016	17
9	Heteroaromatic Pim Kinase Inhibitors Containing a Pyrazole Moiety Recent Patents on Anti-Cancer Drug Discovery ·Pascale Moreau, Fabrice Anizon, F Giraud, Yannick J. Esvan	2016	7
10	Synthesis and activities of new indolopyrrolobenzodiazepine derivatives toward acute myeloid leukemia cells Bioorganic & Medicinal Chemistry ·F Giraud, Marion Bourhis, Edris Ebrahimi, Lars Herfindal, Romy Roy Choudhury, Ronja Bjørnstad, Stein Ove Døskeland, Fabrice Anizon, Pascale Moreau	2015	6
11	Identification of 1,6-dihydropyrazolo[4,3-c]carbazoles and 3,6-dihydropyrazolo[3,4-c]carbazoles as new Pim kinase inhibitors Bioorganic & Medicinal Chemistry ·Virginie Suchaud, Laurent Gavara, Emmanuelle Saugues, Lionel Nauton, Vincent Théry, Fabrice Anizon, Pascale Moreau	2013	25
12	Use of copper(I) catalyzed azide alkyne cycloaddition (CuAAC) for the preparation of conjugated pyrrolo[2,3-a]carbazole Pim kinase inhibitors European Journal of Medicinal Chemistry ·Boris Letribot, Rufine Akué‐Gédu, Niina M. Santio, Malika El‐Ghozzi, Daniel Avignant, Federico Cisnetti, Päivi J. Koskinen, Arnaud Gautier, Fabrice Anizon, Pascale Moreau	2012	22
13	Synthesis, Pim kinase inhibitory potencies and in vitro antiproliferative activities of diversely substituted pyrrolo[2,3-a]carbazoles HAL (Le Centre pour la Communication Scientifique Directe) ·Fabrice Anizon, Rufine Akué‐Gédu, Lionel Nauton, Vincent Théry, Jenny Bain, Philip Cohen, Pascale Moreau	2011	1
14	Synthesis and molecular modeling study of new trimeric quinoline derivatives Bioorganic Chemistry ·Emmanuelle Saugues, Lionel Nauton, Vincent Théry, Fabrice Anizon, Pascale Moreau	2011	4
15	Synthesis and biological activities of new di- and trimeric quinoline derivatives Bioorganic & Medicinal Chemistry ·Sidonie Broch, Hélène Henon, Anne‐Laure Mathieu, Marie‐Laure Fogeron, Nathalie Bonnefoy, Fabrice Anizon, Pascale Moreau	2010	14
16	Fighting Tumor Cell Survival: Advances in the Design and Evaluation of Pim Inhibitors Current Medicinal Chemistry ·Fabrice Anizon, Аlexander А. Shtil, В. Н. Даниленко, Pascale Moreau	2010	41
17	Synthesis and biological activities of aminopyrimidyl-indoles structurally related to meridianins Bioorganic & Medicinal Chemistry ·Rufine Akué‐Gédu, Eric Débiton, Yoan Ferandin, Laurent Meijer, Michelle Prudhomme, Fabrice Anizon, Pascale Moreau	2009	69
18	Rebeccamycin Derivatives as Dual DNA-Damaging Agents and Potent Checkpoint Kinase 1 Inhibitors Molecular Pharmacology ·Christelle Marminon, Fabrice Anizon, Pascale Moreau, Bruno Pfeiffer, Alain St. Pierre, Roy M. Golsteyn, Paul Peixoto, Marie‐Paule Hildebrand, Marie‐Hélène David‐Cordonnier, Olivier Lozach, Laurent Meijer, Michelle Prudhomme	2008	16
19	In-vitro antiproliferative activities and kinase inhibitory potencies of meridianin derivatives Anti-Cancer Drugs ·Emilie Rossignol, Eric Débiton, Doriano Fabbro, Pascale Moreau, Michelle Prudhomme, Fabrice Anizon	2008	23
20	Synthesis and antiproliferative activities of indolin-2-one derivatives bearing amino acid moieties European Journal of Medicinal Chemistry ·Mathieu Sassatelli, Eric Débiton, Bettina Aboab, Michelle Prudhomme, Pascale Moreau	2006	39

About Pascale Moreau

Pascale Moreau is a scholar working on Toxicology, Organic Chemistry, Pathology and Forensic Medicine, Molecular Biology and Pharmacology, having authored 89 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (27 papers), Cancer therapeutics and mechanisms (27 papers), Bioactive Compounds and Antitumor Agents (23 papers), Synthesis and biological activity (23 papers), Synthesis and Biological Evaluation (15 papers), Quinazolinone synthesis and applications (13 papers), Phytochemical compounds biological activities (10 papers) and Microbial Natural Products and Biosynthesis (8 papers). The work is most often cited by research in Toxicology (290 citations), Organic Chemistry (1.1k citations), Pathology and Forensic Medicine (348 citations), Molecular Biology (951 citations) and Pharmacology (182 citations). Pascale Moreau has collaborated with scholars based in France, Russia and Norway. Frequent co-authors include Fabrice Anizon, Michelle Prudhomme, Eric Débiton, F Giraud, Lionel Nauton, Vincent Théry, Martine Sancelme, Rufine Akué‐Gédu, Christian Bailly and Doriano Fabbro. Their work appears in journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Journal of Medicinal Chemistry, Tetrahedron and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact